Superior laryngeal nerve block for the treatment of chronic cough and vocal cord dysfunction (laryngeal sensory neuropathy)

Department of Otolaryngology, Head and Neck surgery, Monash Health0 个研究点目标入组 352 人开始时间: 2019年2月18日最近更新: 2019年7月15日

适应症

试验速览

暂无简介。

•No objective evidence on formal testing and/or failure of adequate treatment to more common causes of treatment:
•Respiratory Disease:
•- Negative Testing: CXR or CT Chest, Broncho-provocation or Broncho-dilation testing
•- No response to an 8 week empirical trial of inhaled corticosteroid
•Allergic Disease:
•- Negative Testing: Negative RAST or Skin prick testing for inhaled allergens
•- No response to an 8 week empirical trial of intranasal and/or oral medications (e.g. Steroid, and/or Anti-histamine)
•Laryngopharyngeal and Gastro-oesophageal Reflux Disease:
•- Negative Testing: Negative Oral Salivary pepsin assay, or 24 hour dual probe pH/impedance monitoring.
•- No response to an 8 week empirical trial of both acid reduction and alginate treatment.

•Are on neuromodulator medications (ie. Tricyclic anti-depressants, SSRIs, Gabapentinoids)
•Are on anti-tussive medications (ie Guafenasin)
•Cannot tolerate an ‘in-office’ procedure
•Known allergy or intolerance to bupivacaine and/or triamcinolone acetate

发起方

Department of Otolaryngology, Head and Neck surgery, Monash Health